- Home
- MAMA vs PHAT Comparison
MAMA vs PHAT Comparison
Compare MAMA & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- PHAT
- Stock Information
- Founded
- MAMA 2010
- PHAT 2018
- Country
- MAMA United States
- PHAT United States
- Employees
- MAMA N/A
- PHAT N/A
- Industry
- MAMA Specialty Foods
- PHAT Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- PHAT Health Care
- Exchange
- MAMA Nasdaq
- PHAT Nasdaq
- Market Cap
- MAMA 242.9M
- PHAT 289.0M
- IPO Year
- MAMA N/A
- PHAT 2019
- Fundamental
- Price
- MAMA $6.46
- PHAT $3.14
- Analyst Decision
- MAMA Strong Buy
- PHAT Strong Buy
- Analyst Count
- MAMA 3
- PHAT 5
- Target Price
- MAMA $10.67
- PHAT $17.80
- AVG Volume (30 Days)
- MAMA 233.3K
- PHAT 2.2M
- Earning Date
- MAMA 06-10-2025
- PHAT 05-01-2025
- Dividend Yield
- MAMA N/A
- PHAT N/A
- EPS Growth
- MAMA N/A
- PHAT N/A
- EPS
- MAMA 0.09
- PHAT N/A
- Revenue
- MAMA $123,328,000.00
- PHAT $81,859,000.00
- Revenue This Year
- MAMA $13.59
- PHAT $201.74
- Revenue Next Year
- MAMA $12.83
- PHAT $114.16
- P/E Ratio
- MAMA $72.11
- PHAT N/A
- Revenue Growth
- MAMA 19.41
- PHAT 3055.70
- 52 Week Low
- MAMA $5.50
- PHAT $2.35
- 52 Week High
- MAMA $9.98
- PHAT $19.71
- Technical
- Relative Strength Index (RSI)
- MAMA 47.87
- PHAT 40.55
- Support Level
- MAMA $6.44
- PHAT $2.21
- Resistance Level
- MAMA $6.90
- PHAT $4.45
- Average True Range (ATR)
- MAMA 0.28
- PHAT 0.42
- MACD
- MAMA 0.01
- PHAT -0.08
- Stochastic Oscillator
- MAMA 39.73
- PHAT 41.52
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.